Related Experiment Video

Updated: Jun 27, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.7K

Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance

Anna Fateeva1,2, Kevinn Eddy1,2, Suzie Chen1,2,3,4

  • 1Susan Lehman Cullman Laboratory for Cancer Research, Rutgers University, Piscataway, NJ 08854, USA.

Cancers
|April 27, 2024
PubMed

Insights

Melanoma treatments like targeted therapy and immunotherapy show promise but face resistance. Understanding resistance mechanisms is key to improving melanoma treatment strategies.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Therapeutics

Background:

  • Melanoma is an aggressive skin cancer with high metastatic potential.
  • Advances in targeted therapy and immunotherapy have improved melanoma treatment outcomes.
  • Therapeutic resistance, both acquired and intrinsic, limits treatment efficacy.

Purpose of the Study:

  • To review current melanoma therapeutic options.
  • To explore mechanisms driving therapeutic resistance in melanoma.
  • To inform the development of strategies to overcome resistance.

Main Methods:

  • Literature review of melanoma therapeutics.
  • Analysis of mechanisms underlying treatment resistance.
  • Synthesis of current knowledge on melanoma therapy resistance.

Main Results:

  • Current melanoma therapies include targeted agents and immunotherapies.
  • Mechanisms of resistance involve genetic mutations, epigenetic alterations, and tumor microenvironment factors.
  • Both acquired and intrinsic resistance significantly impede treatment success.

Conclusions:

  • Overcoming therapeutic resistance is crucial for improving melanoma patient survival.
  • Further research into resistance mechanisms will guide the development of more effective treatments.
  • A deeper understanding of resistance is essential for designing next-generation melanoma therapies.
Keywords:
immunotherapymGluR1melanomariluzoletargeted therapytherapeutic resistance

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.4K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K